Trials / Sponsors / Jacob Soumerai, MD
Jacob Soumerai, MD
Academic / Other · 2 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Withdrawn | Zandelisib + Tazemetostat in R/R Follicular Lymphoma Relapsed Follicular Lymphoma, Refractory Follicular Lymphoma | Phase 1 / Phase 2 | 2023-01-01 |
| Terminated | Belantamab Mafodotin In Plasmablastic Lymphoma & ALK+ Large B-Cell Lymphoma Relapsed Plasmablastic Lymphoma, Refractory Plasmablastic Lymphoma, Anaplastic Lymphoma Kinase Positive Large B-Cell Lymphoma | Phase 2 | 2021-07-01 |